Hit to trading terms

Wholesalers forced to act in the wake of direct distribution defections The recent moves by manufacturers AstraZeneca and Amgen to a direct distribution model are being blamed for driving full-line wholesalers to reduce their trading terms to pharmacies. Earlier this week industry newsletter Pharma In Focus reported that Sigma was believed to be winding back

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacist faces ice, cocaine & prescription drug charges
Next Why was the flu vaccination so ineffective?